Expanding the manufacturing capacity for cell and gene therapies: an interview with Julie G Allickson

Research output: Contribution to journalReview articlepeer-review

Abstract

Julie G Allickson, PhD, is the Michael S and Mary Sue Shannon Family Director of Mayo Clinic's Center for Regenerative Biotherapeutics at Mayo Clinic (Minnesota, Florida and Arizona) and the Otto Bremer Trust Director, Biomanufacturing and Product Development, Center for Regenerative Biotherapeutics. With over 25 years of experience in regenerative medicine, cellular therapies and regulatory affairs, Dr Allickson leads the center as it pivots toward biomanufacturing, ensuring that discoveries are successful for clinical translation and eventually commercialization. The center is in the process of building their industry experienced team on all pillars of biomanufacturing to support clinical and principal investigators at the Mayo Clinic.

Original languageEnglish (US)
Pages (from-to)373-375
Number of pages3
JournalRegenerative Medicine
Volume18
Issue number5
DOIs
StatePublished - May 1 2023

Keywords

  • cell therapy
  • gene therapy
  • manufacturing capacity
  • workforce development

ASJC Scopus subject areas

  • Biomedical Engineering
  • Embryology

Fingerprint

Dive into the research topics of 'Expanding the manufacturing capacity for cell and gene therapies: an interview with Julie G Allickson'. Together they form a unique fingerprint.

Cite this